Contact Information
  • 800-826-HOPE (4673)
Joseph Rosenthal, M.D.
  • Professor, Pediatrics
  • Barron Hilton Chair in Pediatrics
  • Director, Pediatric Hematology/Oncology

Primary Specialties

Clinical Area / Sub-specialties

Departments/Division/Program

Languages Spoken
  • Hebrew

Professional Experience

  • 2011 - present, Chair, Department of Pediatrics, City of Hope, Duarte, CA
  • 2011 - present, Director, Pediatric Hematology/Oncology, City of Hope, Duarte, CA
  • 2009 - 2011, Interim Chair, Department of Pediatrics, Duarte, CA
  • 2002 - 2011, Associate Professor and Director, Pediatric Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
  • 1996 - 2002, Assistant Professor and Director, Pediatric Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
  • 1993 - 1995, Hematology/Oncology, Blood and Bone Marrow Transplant Program, Children's Hospital of Orange County, Orange, CA
  • 1992 - 1993, Pediatric Oncology Faculty, Famban Medical Center, Haifa, Isreal
  • 1991 - 1992, Pediatric Hematology/Oncology Faculty, Soroka Medical Center, Beer Sheba, Israel
  • 1987 - 1988, Pediatric Hematology/Oncology, Sambur Center, Bellinson Hospital, Petach Tiqua, Israel

Education

Education/Training
  • 2003, Harvard School of Public Health, Boston, MA, Masters Health Care Management
  • 1991, University of Colorado, Denver, CO, Fellowship, Pediatric Hematology/Oncology
  • 1987, Soroka Medical Center, Beer Sheba, Israel, Residency, Medicine
  • 1982, Soroka Medical Center, Beer Sheba, Israel, Internship, Medicine
  • 1981, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, M.D.
  • 1975, Hebrew University, Jerusalem, Israel, B.Sc.

Board Certifications/Licensure
  • California State Medical License (current)
  • Israel Medical License (permanent)
  • American Board of Pediatric Hematology/Oncology (1996)
  • American Board of Pediatrics (1995)
  • FLEX (1990)
  • Israel Board of Pediatrics (1987)

Memberships

  • 1987, Hematology Research Laboratory, Soroka Medical Center, Beer Sheba, Israel

Publications

  • Rosenthal J, Pawlowska A, Bolotin E, Cervantes C, Maroongroge S, Forman S. Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus. Pediatric Blood Cancer (accepted for publication September 2010).
  • Rosenthal J, Wong J, Stein A, Qian D, Hitt D, Naeem H, Dagis, A, Thomas SH, Forman S. Phase I/II trial of total marrow and lymph node irradiation to augment reduced intensity transplant for advanced hematological malignancies. Blood. 2010 Sept. 28 (Epub ahead of print)
  • Rodriguez R, Nakamura R, Palmer P, Shayani S, Nademanee A, Synder D, Pullarkat V, Kogut N, Rosenthal J, Smith E, Karanes C, O'Donnell M, Krishnan AY, Senitzer D, and Forman SJ. A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplant using three conditioning regimens. Blood 115(5):1098-105, 2010.
  • Behrendt CE, Rosenthal J, Bolotin E, Nakamura R, Zaia J, Forman SJ. Donor and Recipient CMV Serostatus and Outcome of Pediatric Allogeneic HSCT for Acute Leukemia in the Era of CME-Preemptive Therapy. Biol Blood Marrow Transplant. 15:54-60, 2009.
  • Wong JY, Rosenthal J, Liu A, Schultheiss T, Forman S, Somlo G. Image-Guided Total-Marrow Irradiation Using Helical TomoTherapy in Patients with Multiple Myeloma and Acute Leukemia Undergoing Hematopoietic Cell Transplantation. Int J Radiat Oncol Biol Phys. 73(1):273-9, 2009.
  • Bunin, NJ, Davies DM, Alpenc, R, Camitta, BM, DeSantes KD, Goyal, RK, Kapoor N, Kernan, NA, Rosenthal J, Smith FO, Eapen, M. Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy. J Clin Oncol. 10;26(26):4326-32, 2008.
  • Rosenthal J, Bolotin E, Shakhnovits M, Pawlowska A, Falk P, Qian D, Oliver C, Sato J, Miser J, Forman S. High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors. Bone Marrow Transplant. 42(5):311-8, 2008.
  • Rodgers GM 3rd, Becker PS, Bennett CL, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Djulbegovic B, Garst JL, Gilreath JA, Kraut EH, Lin WC, Matulonis U, Millenson M, Reinke D, Rosenthal J, Sabbatini P, Schwartz RN, Stein RS, Vij R. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw. 1;6(6):536-64, 2008.

Locations

  • City of Hope - Main Campus (Duarte)
    1500 East Duarte Road
    Duarte, CA 91010

Biography

Joseph (Yossi) Rosenthal, M.D., is chair of the Department of Pediatrics at City of Hope. Dr. Rosenthal is also the holder of the Barron Hilton Chair in Pediatrics. He is known as a national leader in improving outcomes for children with cancer, an excellent collaborator and a kind and caring individual.

Dr. Rosenthal first came to City of Hope in 1996, serving as Director of the Pediatric Bone Marrow Transplantation service for many years, and later serving as the Interim Chair of the Department of Pediatrics from 2009 through 2011. He is an outstanding clinician, with research interests and accomplishments in the areas of pediatric leukemia and stem cell transplantation. 

He attended medical school at the Sackler School of Medicine, Tel Aviv University in Israel, completed internship and residency at Soroka Medical Center in Beer Sheba, Israel, and then spent a year in pediatric hematology/oncology at the Sambur Center, Beilinson Hospital in Petach Tiqva, Israel.  He moved to the United States in 1988, where he competed a fellowship in Pediatric Hematology/Oncology at the University of Colorado School of Medicine, followed by an additional two years of fellowship in Pediatric Cancer Research and Bone Marrow Transplantation at the Children’s Hospital of Orange County.  Dr. Rosenthal also received a degree in Health Care Management from the Harvard School of Public Health in Boston.